2013-2028 Report on Global G-CSF Biosimilars Market by Player, Region, Type, Application and Sales Channel


Report ID : RC-51109 Category : Pharmaceuticals
Published Date : Oct-19 Pages : 115 Format : PDF
The global G-CSF Biosimilars market was valued at $XX million in 2018, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.

This report provides detailed historical analysis of global market for G-CSF Biosimilars from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the G-CSF Biosimilars market.

Leading players of G-CSF Biosimilars including:
    Pfizer
    Novartis
    Roche
    Merck & Co.
    Sanofi
    Johnson & Johnson
    Gilead Science
    GlaxoSmithKline
    AbbVie
    Amgen
    AstraZeneca
    Bayer

Market split by Type, can be divided into:
    Human Growth Hormone
    Erythropoietin
    Monoclonal Antibodies
    Insulin
    Interferon
    Granulocyte-Colony Stimulating Factor

Market split by Application, can be divided into:
    Blood Disorders
    Oncology Diseases
    Chronic And Autoimmune Diseases
    Growth Hormone Deficiencies

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 G-CSF Biosimilars Market Overview
    1.1 G-CSF Biosimilars Definition
    1.2 Global G-CSF Biosimilars Market Size Status and Outlook (2013-2028)
    1.3 Global G-CSF Biosimilars Market Size Comparison by Region (2013-2028)
    1.4 Global G-CSF Biosimilars Market Size Comparison by Type (2013-2028)
    1.5 Global G-CSF Biosimilars Market Size Comparison by Application (2013-2028)
    1.6 Global G-CSF Biosimilars Market Size Comparison by Sales Channel (2013-2028)
    1.7 G-CSF Biosimilars Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 G-CSF Biosimilars Market Segment Analysis by Player
    2.1 Global G-CSF Biosimilars Sales and Market Share by Player (2016-2018)
    2.2 Global G-CSF Biosimilars Revenue and Market Share by Player (2016-2018)
    2.3 Global G-CSF Biosimilars Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 G-CSF Biosimilars Market Segment Analysis by Type
    3.1 Global G-CSF Biosimilars Market by Type
        3.1.1 Human Growth Hormone
        3.1.2 Erythropoietin
        3.1.3 Monoclonal Antibodies
        3.1.4 Insulin
        3.1.5 Interferon
    3.2 Global G-CSF Biosimilars Sales and Market Share by Type (2013-2018)
    3.3 Global G-CSF Biosimilars Revenue and Market Share by Type (2013-2018)
    3.4 Global G-CSF Biosimilars Average Price by Type (2013-2018)
    3.5 Leading Players of G-CSF Biosimilars by Type in 2018
    3.6 Conclusion of Segment by Type
Chapter 4 G-CSF Biosimilars Market Segment Analysis by Application
    4.1 Global G-CSF Biosimilars Market by Application
        4.1.1 Blood Disorders
        4.1.2 Oncology Diseases
        4.1.3 Chronic And Autoimmune Diseases
        4.1.4 Growth Hormone Deficiencies
    4.2 Global G-CSF Biosimilars Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of G-CSF Biosimilars by Application in 2018
    4.4 Conclusion of Segment by Application
Chapter 5 G-CSF Biosimilars Market Segment Analysis by Sales Channel
    5.1 Global G-CSF Biosimilars Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global G-CSF Biosimilars Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of G-CSF Biosimilars by Sales Channel in 2018
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 G-CSF Biosimilars Market Segment Analysis by Region
    6.1 Global G-CSF Biosimilars Market Size and CAGR by Region (2013-2028)
    6.2 Global G-CSF Biosimilars Sales and Market Share by Region (2013-2018)
    6.3 Global G-CSF Biosimilars Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America G-CSF Biosimilars Market Share by Type
        6.4.3 North America G-CSF Biosimilars Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe G-CSF Biosimilars Market Share by Type
        6.5.3 Europe G-CSF Biosimilars Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific G-CSF Biosimilars Market Share by Type
        6.6.3 Asia-Pacific G-CSF Biosimilars Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America G-CSF Biosimilars Market Share by Type
        6.7.3 South America G-CSF Biosimilars Market Share by Application
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa G-CSF Biosimilars Market Share by Type
        6.8.3 Middle East & Africa G-CSF Biosimilars Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading G-CSF Biosimilars Players
    7.1 Pfizer
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Novartis
    7.3 Roche
    7.4 Merck & Co.
    7.5 Sanofi
    7.6 Johnson & Johnson
    7.7 Gilead Science
    7.8 GlaxoSmithKline
    7.9 AbbVie
    7.10 Amgen
    7.11 AstraZeneca
    7.12 Bayer
Chapter 8 Upstream and Downstream Analysis of G-CSF Biosimilars
    8.1 Industrial Chain of G-CSF Biosimilars
    8.2 Upstream of G-CSF Biosimilars
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of G-CSF Biosimilars
        8.3.1 Leading Distributors/Dealers of G-CSF Biosimilars
        8.3.2 Leading Consumers of G-CSF Biosimilars
Chapter 9 Development Trend of G-CSF Biosimilars (2019-2028)
    9.1 Global G-CSF Biosimilars Market Size (Sales and Revenue) Forecast (2019-2028)
    9.2 Global G-CSF Biosimilars Market Size and CAGR Forecast by Region (2019-2028)
    9.3 Global G-CSF Biosimilars Market Size and CAGR Forecast by Type (2019-2028)
    9.4 Global G-CSF Biosimilars Market Size and CAGR Forecast by Application (2019-2028)
    9.5 Global G-CSF Biosimilars Market Size Forecast by Sales Channel (2019-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification

Sidebar Menu